Munehiko Hirano

TL;DR: Percutaneously absorbable preparations which comprise, by weight, 0.001 to 20%, preferably 0.1 to 20, of 3-l-menthoxy-propane-1,2-diol as a solubilizer for a drug and 0.5 to 10%, of the drug as two essential ingredients, the balance being other ingredients as adjuvants selected from water-soluble polymers, monohydric alcohols, polyhydric alcohol, rosin esters, water, fatty acid esters and hydrocarbons, softening agents,

TL;DR: A sheet-form adhesive preparation which gives a comfortable refreshing feeling in use, gives a wet feeling to the skin, and is usable as a cosmetic, medicinal, or quasi-drug preparation for the sake of skin adjustment and beauty.

TL;DR: A percutaneous preparation containing estradiol as the pharmaceutically active ingredient and the following components as the base: (1) an elastic polymer of the formula (A-B)nX or (A)-Bn-A, wherein A represents substantially a block of a monovinyl-substituted aromatic compound polymer, B represents substantially the block of conjugated diolefin copolymer, n is an integer of 3 to 7, and X represents a residue of a polyfunctional compound to which are bonded n polymer (A -B

TL;DR: An anti-inflammatory analgesic plaster containing the following components as the essential ingredients: (a) a nonsteroidal anti-inflammation analgesic comprising at least one member selected from the group consisting of ketoprofen, flurbiprofen and loxopprofen, ketorolac, and ester derivatives and salts thereof; (b) a solvent comprising both of a rosin ester derivative and l-methol; (c) a styrene/isoprene/styrene block copolymer as the base polymer; (d

TL;DR: A percutaneously absorbable patch containing an elastic polymer (A-B)n-A (wherein A represents substantially a monovinylaromatic polymer block, B represents a conjugated diolefin copolymer block, and n represents an integer of 3 to 7) as the base ingredient, crotamiton and an emollient each as the essential ingredient, and at least two types of hormones, particularly an estrogen and a progesterone, each as an active ingredient as mentioned in this paper.